AI assistant
Sending…
Indaptus Therapeutics, Inc. — Director's Dealing 2023
May 30, 2023
35475_dirs_2023-05-30_b07ee4cc-ef6e-4fad-a872-02e9b921eac3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2023-05-25
Reporting Person: MADDALUNA ANTHONY J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-25 | Stock Option (right to buy) | $1.82 | A | 12500 | Acquired | 2033-05-25 | Common Stock (12500) | Direct |
Footnotes
F1: The stock option vests and becomes exercisable on May 25, 2024.
More from Indaptus Therapeutics, Inc.
Board/Management Information
2026
Jun 5
Interim / Quarterly Report
2026
May 15
Report Publication Announcement
2026
May 15
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 3
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 27
Director's Dealing
2026
Feb 13
Capital/Financing Update
2026
Feb 12